logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Usher III Initiative, Inc.


USPTO Granted Patents = 10



Forward Citations = 37

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Karine Fabienne Malagu (9 out of 25 patents)

silverMedal Roland Werner Bürli (9 out of 10 patents)

bronzeMedal Christopher James Lock (9 out of 10 patents)

4.  Andrew Pate Owens (9 out of 33 patents)

5.  William E Harte (9 out of 9 patents)

6.  William Rameshchandra Krishna Esmieu (8 out of 8 patents)

7.  William Rameschandra Krishna Esmieu (1 out of 1 patent)

8.  James M Hamby (1 out of 3 patents)

9.  Tracey L Fletcher (1 out of 1 patent)

10.  Mahdi Farhan (1 out of 1 patent)

11.  Roland Werner Burli (2 patents)

12.  David A Saperstein (7 patents)

13.  William Rameshchandra Esmieu (0 patent)

14.  William Edward Harte (0 patent)

15.  William Edward Harte (0 patent)


10 patents:

1. 12544373 - Treatment of cancer, inflammatory diseases and autoimmune diseases (2026-02-10),
2. 10307422 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2019-06-04),
3. 9925187 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2018-03-27),
4. 9783545 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2017-10-10),
5. 9549910 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2017-01-24),
6. 9371332 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome (2016-06-21),
7. 9260381 - Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome (2016-02-16),
8. 9227976 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2016-01-05),
9. 9079909 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome (2015-07-14),
10. 8765762 - Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome (2014-07-01),
Company Overview
Usher III Initiative, Inc. is a Chicago-based organization focused on advancing innovative solutions in the field of assistive technology. The initiative specializes in developing products and services aimed at enhancing the quality of life for individuals with hearing and vision impairments. By leveraging cutting-edge research and technology, Usher III Initiative seeks to create impactful tools that promote accessibility and inclusion, fostering a more equitable environment for all users.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#350 in Chicago, IL

#1,442 in Illinois

#29,866 in US

#56,047 in the World

Chicago, IL (US)
Chicago, IL, United States of America

Usher III Initiative, Inc.

Forward Citations = 37

10 inventors:

goldMedal Karine Fabienne Malagu (9 out of 25 patents)

silverMedal Roland Werner Bürli (9 out of 10 patents)

bronzeMedal Christopher James Lock (9 out of 10 patents)

4.  Andrew Pate Owens (9 out of 33 patents)

5.  William E Harte (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Usher III Initiative, Inc.. Retrieved from https://idiyas.com/company/usher-iii-initiative

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…